HarNeedi - Healthcare & Pharma Job Portal

Healthcare & Pharma Articles

Budget parivarthan Tagged Posts

How budget parivarthan changing drug companies future?

The Government of India contrives to amend the Drugs and Cosmetics (D&C) rules to assure availability of medicines at reasonable costs and use of generic medicines, the finance minister (FM) proclaimed in the union budget for 2017-2018.

New rules will be designed for medical devices, which will help in optimizing the prices of such devices. “It’s a clear message from Govt. Of India that they putting efforts to amend the medical devices rules as to harmonize international standards and attract more investment into the sector”.

Initiatives from government has already brought for instance coronary stents under price control and demanded National Pharmaceutical Pricing Authority (NPPA) to set its ceiling price. This step has been met with resistance from the producers of medical device in the country.

Read more @ https://goo.gl/ys6bde

For more updates visit HarNeedi.com

continue reading
2 readers |0 Comments|Reply

How budget parivarthan changing drug companies future?

The Government of India contrives to amend the Drugs and Cosmetics (D&C) rules to assure availability of medicines at reasonable costs and use of generic medicines, the finance minister (FM) proclaimed in the union budget for 2017-2018.

New rules will be designed for medical devices, which will help in optimizing the prices of such devices. “It’s a clear message from Govt. Of India that they putting efforts to amend the medical devices rules as to harmonize international standards and attract more investment into the sector”.

Initiatives from government has already brought for instance coronary stents under price control and demanded National Pharmaceutical Pricing Authority (NPPA) to set its ceiling price. This step has been met with resistance from the producers of medical device in the country.

Read more @ https://goo.gl/ys6bde

For more updates visit HarNeedi.com

continue reading
0 readers |0 Comments|Reply
[]